I agree that this site is using cookies. You can find further informations here.
X
Traboulsee, Anthony L.
442  results:
Search for persons X
?
1

Anti-aquaporin-4 immune complex stimulates complement-depen..:

Nishiyama, Shuhei ; Seok, Jin Myong ; Wright, Amy E....
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Sécurité et efficacité clinique du Tolebrutinib dans l'étud..:

Oh, Jiwon ; Reich, Daniel S. ; Traboulsee, Anthony...
Revue Neurologique.  180 (2024)  - p. S158-S159 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Efficacité à long terme du satralizumab dans les troubles d..:

De Sèze, Jérôme ; Palace, Jacqueline ; Traboulsee, Anthony...
Revue Neurologique.  180 (2024)  - p. S59 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Health Canada drug approval process: a barrier to personali..:

Oh, Jiwon ; Bhan, Virender ; Traboulsee, Anthony...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  , 2024
Link: https://doi.org/10.1017/..
 
?
5

Myelin Water Fraction of Slowly Evolving Lesions is Associa..:

Zhuang, Rebecca ; Vavasour, Irene ; Elliott, Colm...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
6

Cancer risk, disease-modifying therapy, and age in multiple..:

Greenfield, Jamie ; Metz, Luanne M. ; Khakban, Amir...
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105091 , 2023
Link: https://doi.org/10.1016/..
 
?
7

SAkuraBONSAI: Protocol design of a novel, prospective study..:

Bennett, Jeffrey L. ; Fujihara, Kazuo ; Kim, Ho Jin...
Frontiers in Neurology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

Progressive steps towards a standardized MRI protocol for p..:

Li, David ; Yim, Samuel ; Barlow, Laura...
Journal of the Neurological Sciences.  455 (2023)  - p. 121861 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Ocrelizumab exposure in relapsing–remitting multiple sclero..:

Kappos, Ludwig ; Traboulsee, Anthony ; Li, David K. B....
Journal of Neurology.  271 (2023)  2 - p. 642-657 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Safety and efficacy with alemtuzumab over 13 years in relap..:

Coles, Alasdair J. ; Achiron, Anat ; Traboulsee, Anthony...
Therapeutic Advances in Neurological Disorders.  16 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
11

Direct Health Care Costs Associated With Multiple Sclerosis..:

Khakban, Amir ; Rodriguez Llorian, Elisabet ; Michaux, Kristina D....
Neurology.  100 (2023)  9 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
12

Lack of Rebound Disease Activity in Participants with Relap..:

Traboulsee, Anthony ; Fox, Robert ; Arnold, Douglas...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
13

Long-Term Treatment With First-Line Ocrelizumab in Patients..:

Cerqueira, Joao ; Berthele, Achim ; Cree, Bruce...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
14

International Consensus on Smoldering Disease in Multiple S..:

Bagnato, Francesca ; Scalfari, Antonio ; Oh, Jiwon...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
15

Long-term Efficacy of Satralizumab in Adults with Aquaporin..:

Traboulsee, Anthony ; Kleiter, Ingo ; Palace, Jacqueline...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
1-15